A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22.
about
A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@ast
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@en
type
label
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@ast
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@en
prefLabel
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@ast
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@en
P2093
P2860
P1433
P1476
A phase I/II trial of epirubic ...... kly schedules: NCIC CTG MA.22.
@en
P2093
Amadeo M Parissenti
Baoqing Guo
Harriette J Kahn
Judith-Anne W Chapman
Kathleen I Pritchard
Lois E Shepherd
Mark J Clemons
Maureen Elizabeth Trudeau
Patti O'Brien
P2860
P2888
P356
10.1186/S40064-015-1392-X
P577
2015-10-21T00:00:00Z
P5875
P6179
1042587895